Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Influence of Rhythm and Interpersonal Relationship on Gait Parameters in Children With Autism Spectrum Disorder

1 oktober 2026 bijgewerkt door: Estrada Barranco, Universidad Europea de Madrid

Influence of Rhythm and Interpersonal Relationship on Gait Parameters in Children With Autism Spectrum Disorder: A Controlled Intervention Study

Autism Spectrum Disorder (ASD) is associated with differences in social communication, motor coordination, interpersonal synchronization, and gait. This randomized crossover study examined the influence of walking pace and social familiarity on gait parameters in 30 children aged 4-6 years with ASD. Participants completed 10-metre walking trials at three pacing conditions (100, 120, and 140 beats per minute) while walking alongside either their mother or an unfamiliar researcher. The order of the two social conditions was randomized, and all participants completed both conditions. Spatiotemporal and lower-limb kinematic gait parameters were assessed from video recordings.

Studie Overzicht

Gedetailleerde beschrijving

Study Design:

This randomized crossover interventional study assessed the influence of walking pace and social familiarity on gait parameters in children diagnosed with Autism Spectrum Disorder (ASD). The study included 30 children aged 4-6 years with ASD level I or II who were able to walk independently without assistive devices. Participants were recruited from Fundación AMÁS, an early intervention centre.

Participants were randomly assigned to one of two sequences. Fifteen participants completed the mother condition first, followed by the unfamiliar-researcher condition, and fifteen completed the unfamiliar-researcher condition first, followed by the mother condition. All participants therefore completed both social walking conditions. Randomization applied to the order of the social conditions.

Walking Procedure:

Participants completed walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, the child walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants.

The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. Each child completed three repetitions of a 10-metre walk in each condition.

Video recordings were obtained from a lateral view under standardized recording conditions. Only the central 2 metres of the final repetition were analysed to exclude the acceleration and deceleration phases. Gait parameters were assessed from the recordings using Kinovea® software.

Outcome Measures:

The assessed outcomes were gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles at eight predefined events and phases of the gait cycle: initial contact, loading response, mid-stance, terminal stance, pre-swing, initial swing, mid-swing, and terminal swing.

Study Population:

Eligible participants were children aged 4-6 years with a clinical diagnosis of ASD level I or II who attended regular therapy sessions at Fundación AMÁS and were able to walk independently. Children with associated syndromes or recent interventions affecting the lower limbs were excluded.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

30

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Madrid
      • Madrid, Madrid, Spanje, 28670
        • Universidad Europea de Madrid

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

4 jaar tot 6 jaar (Kind)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Children aged 4 to 6 years.
  • Clinical diagnosis of Autism Spectrum Disorder (ASD) (Level I or II).
  • Ability to walk independently without the use of assistive devices.
  • Parents or legal guardians provide informed consent for participation.

Exclusion Criteria:

  • Presence of other syndromes or developmental disorders.
  • History of recent surgical interventions or procedures involving the lower limbs.
  • Significant neurological or orthopedic conditions that may affect gait.
  • Any contraindications for participation in physical activities as determined by the child's healthcare provider.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Fundamentele wetenschap
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Crossover-opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Mother-first sequence

Fifteen participants first completed the walking trials alongside their mother and subsequently crossed over to complete the trials alongside the unfamiliar researcher. Participants performed the walking task under the three pacing conditions (100, 120, and 140 bpm).

Participants completed 10-metre walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, participants walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants. The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. All participants completed both social conditions, with the order of the mother and unfamiliar-researcher conditions determined by random allocation. Gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles were assessed from video recordings using Kinovea® software.

Experimenteel: Unfamiliar-researcher-first sequence

Fifteen participants first completed the walking trials alongside the unfamiliar researcher and subsequently crossed over to complete the trials alongside their mother. Participants performed the walking task under the three pacing conditions (100, 120, and 140 bpm).

Participants completed 10-metre walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, participants walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants. The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. All participants completed both social conditions, with the order of the mother and unfamiliar-researcher conditions determined by random allocation. Gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles were assessed from video recordings using Kinovea® software.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Cadence
Tijdsspanne: During each walking condition within a single assessment session.

The number of steps taken per minute.

During each walking condition within a single assessment session.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Step Length
Tijdsspanne: During each walking condition within a single assessment session.

The distance covered in a single step, measured in meters

During each walking condition within a single assessment session.
Step Time: The duration of each step, measured in seconds
Tijdsspanne: During each walking condition within a single assessment session.

The duration of each step, measured in seconds

During each walking condition within a single assessment session.
Velocity:
Tijdsspanne: During each walking condition within a single assessment session.

The speed of walking, measured in meters per second.

During each walking condition within a single assessment session.
Joint Amplitudes
Tijdsspanne: During each walking condition within a single assessment session.

The angles at which the hip, knee, and ankle joints move during each phase of the gait cycle, assessed in degrees

During each walking condition within a single assessment session.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 februari 2024

Primaire voltooiing (Werkelijk)

31 mei 2024

Studie voltooiing (Werkelijk)

31 mei 2024

Studieregistratiedata

Eerst ingediend

4 oktober 2024

Eerst ingediend dat voldeed aan de QC-criteria

23 oktober 2024

Eerst geplaatst (Werkelijk)

26 oktober 2024

Updates van studierecords

Laatste update geplaatst (Werkelijk)

6 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

1 oktober 2026

Laatst geverifieerd

1 oktober 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Data Sensitivity: Given that the study focuses on a vulnerable population (children with Autism Spectrum Disorder), there are heightened concerns regarding the misuse or misinterpretation of the data.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren